About IBB

The Born-Bunge Institute (IBB) at the University of Antwerp wants to assist patients via their treating physician by:

  • making a definite neuropathological diagnosis
  • or by developing new research methods on the basis of body material.

Depending on the pathology, research is carried out on brain, spinal cord, blood or derivatives, cerebrospinal fluid, muscle tissue, skin or nerves, fatty tissue, etc.

The IBB offers the possibility to store this body material together with clinical data for a longer period of time under strict conditions in its IBB-NeuroBiobank.
 Scientists can borrow these body materials upon submission of a research request approved by a Medical Ethics Committee.

This provides scientists with unique opportunities to conduct important research, under controlled conditions, into neurodegenerative and neuromuscular diseases such as, but not limited to:

  • Alzheimer's disease (AD)
  • Parkinson's disease (PD)
  • Frontotemporal lobar degeneration/dementia (FT(L)D)
  • Dementia with Lewy bodies (DLB)
  • Cerebrovascular degeneration (CVD)
  • Multiple system atrophy (MSA)
  • Progressive supranuclear paralysis (PSP)
  • Corticobasal degeneration (CBD)
  • Creutzfeldt-Jakob Disease (CJD)
  • Amyotrophic lateral sclerosis (ALS)
  • Adrenomyeloneuropathy
  • Congenital fibre-type disproportion (CFTD)
  • Central pontine myelinolysis (CPM)
  • Leukodystrophy (adreno, metachromatic, etc.)
  • Multifocal motor neuropathy (MMN)
  • Multiple sclerosis (MS)
  • Spinal muscular atrophy (SMA)
  • Spinocerebellar atrophy (SCA)
  • Down syndrome
  • Age-related healthy control individuals